AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 276: H530-H534, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sörensson, J.
Right arrow Articles by Haraldsson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sörensson, J.
Right arrow Articles by Haraldsson, B.
Vol. 276, Issue 2, H530-H534, February 1999

Human endothelial cells produce orosomucoid, an important component of the capillary barrier

Jenny Sörensson1, Göran L. Matejka2, Maria Ohlson1, and Börje Haraldsson1,2

1 Department of Physiology, Göteborg University, and 2 Department of Internal Medicine, Research Center for Endocrinology and Metabolism, Sahlgrenska University Hospital, SE-405 30 Göteborg, Sweden

The serum protein orosomucoid (alpha 1-acid glycoprotein) is needed to maintain the high capillary permselectivity required for normal homeostasis. It is not known how the protein executes its action, but it seems to contribute to the charge barrier. Moreover, recent studies suggest that the endothelial glycocalyx is essential for the charge barrier. The main site of orosomucoid synthesis is the liver, but we wanted to explore the possibility that orosomucoid was synthesized in endothelial cells. Primary cultures of human microvascular endothelial cells (HMVEC) from dermal tissue were established. Human liver cells were used as positive controls, and total RNA was prepared from both cell types. Reverse transcription-polymerase chain reaction (RT-PCR) was performed and demonstrated orosomucoid expression. After RT-PCR, the identities of the PCR products were confirmed by sequencing. RNase protection assay performed on total RNA from the HMVEC confirmed the results from the RT-PCR, i.e., orosomucoid mRNA is expressed by endothelial cells. Synthesis of orosomucoid in both liver and endothelial cells was demonstrated by immunoprecipitation. In conclusion, endothelial cells normally produce orosomucoid, which is essential for capillary charge selectivity. We suggest that orosomucoid exerts its effect by interacting with other components of the endothelial glycocalyx.

glycocalyx; alpha 1-acid glycoprotein; capillary permeability


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
B. Haraldsson, J. Nystrom, and W. M. Deen
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Physiol Rev, April 1, 2008; 88(2): 451 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Bjornson, J. Moses, A. Ingemansson, B. Haraldsson, and J. Sorensson
Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F748 - F756.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Bowler, B. Duda, E. D. Chan, J. J. Enghild, L. B. Ware, M. A. Matthay, and M. W. Duncan
Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1095 - L1104.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
B. Haraldsson and J. Sorensson
Why Do We Not All Have Proteinuria? An Update of Our Current Understanding of the Glomerular Barrier
Physiology, February 1, 2004; 19(1): 7 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. Sorensson, A. Bjornson, M. Ohlson, B. J. Ballermann, and B. Haraldsson
Synthesis of sulfated proteoglycans by bovine glomerular endothelial cells in culture
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F373 - F380.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
T Hochepied, A Wullaert, F G Berger, H Baumann, P Brouckaert, L Steidler, and C Libert
Overexpression of {alpha}1-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis
Gut, September 1, 2002; 51(3): 398 - 404.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Constantinescu, H. Vink, and J. A. E. Spaan
Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1051 - H1057.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Hochepied, W. Van Molle, F. G. Berger, H. Baumann, and C. Libert
Involvement of the Acute Phase Protein alpha 1-Acid Glycoprotein in Nonspecific Resistance to a Lethal Gram-negative Infection
J. Biol. Chem., May 12, 2000; 275(20): 14903 - 14909.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Sorensson, M. Ohlson, A. Bjornson, and B. Haraldsson
Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine
Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1725 - H1731.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Boncela, I. Papiewska, I. Fijalkowska, B. Walkowiak, and C. S. Cierniewski
Acute Phase Protein alpha 1-Acid Glycoprotein Interacts with Plasminogen Activator Inhibitor Type 1 and Stabilizes Its Inhibitory Activity
J. Biol. Chem., September 14, 2001; 276(38): 35305 - 35311.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online